{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:21:08Z","timestamp":1772094068689,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7115,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1023\/a:1008355315205","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"845-849","source":"Crossref","is-referenced-by-count":52,"title":["Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck"],"prefix":"10.1016","volume":"11","author":[{"given":"L.","family":"Specht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Kornum","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Sand","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008355315205_bb0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.annonc.a058906","volume":"5","author":"Clavel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008355315205_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","article-title":"A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck","volume":"10","author":"Jacobs","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0015","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1992.10.8.1245","article-title":"Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study","volume":"10","author":"Forastiere","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/bjc.1990.59","article-title":"A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end-stage squamous-cell carcinoma of the head and neck","volume":"61","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008355315205_bb0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1023\/A:1008203613364","article-title":"Chemotherapy for symptom control in recurrent squamous-cell carcinoma of the head and neck","volume":"8","author":"Constenla","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008355315205_bb0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.bjc.6690715","article-title":"A phase II study of docetaxel in patients with metastatic squamous-cell carcinoma of the head and neck","volume":"81","author":"Couteau","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008355315205_bb0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/oxfordjournals.annonc.a058908","article-title":"Docetaxel (Taxotere\u00ae): An active drug for the treatment of patients with advanced squamous-cell carcinoma of the head and neck","volume":"5","author":"Catimel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008355315205_bb0040","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1996.14.5.1672","article-title":"Docetaxel: An active drug for squamous-cell carcinoma of the head and neck","volume":"14","author":"Dreyfuss","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1997.15.3.1071","article-title":"Phase I and pharmacologic study of docetaxel and cisplatin in patients with solid tumors","volume":"15","author":"Pronk","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1023\/A:1008355315205_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1008355315205_bb0060","series-title":"National Cancer Institute, Division of Cancer Treatment","year":"1994"},{"key":"10.1023\/A:1008355315205_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1008360323986","article-title":"Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous-cell carcinoma of the head and neck","volume":"10","author":"Sch\u00f6ffski","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008355315205_bb0070","first-page":"399a","article-title":"A phase II study of docetaxel and cisplatin in patients with locally advanced, recurrent, and\/or metastatic squamous-cell carcinoma of the head and neck (SCCHN), not curable by standard therapy","volume":"17","author":"Forastiere","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0075","first-page":"398a","article-title":"A phase II study of docetaxel (DTX) + cisplatin (CDDP) in locally advanced and metastatic squamous-cell carcinoma of the head and neck","volume":"18","author":"Manzione","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0080","first-page":"401a","article-title":"Phase II study of docetaxel and cisplatin as induction chemotherapy in locally advanced squamous-cell carcinoma of the head and neck (SCCHN): Preliminary results","volume":"18","author":"Mel","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl 4","key":"10.1023\/A:1008355315205_bb0085","first-page":"75","article-title":"First-line therapy in head and neck cancer (HNC) with docetaxel (D)-cisplatin (P)","volume":"9","author":"Baur","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008355315205_bb0090","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment","volume":"16","author":"Semb","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008355315205_bb0095","first-page":"4751","article-title":"Advanced head and neck cancer and clinical experience of an effective new agent: Docetaxel","volume":"18","author":"Sch\u00f6ffski","year":"1998","journal-title":"Anticancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419553923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419553923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/7\/845\/19478623\/11-7-845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:18:40Z","timestamp":1582165120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419553923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0923753419553923"],"URL":"https:\/\/doi.org\/10.1023\/a:1008355315205","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}